Obalon Therapeutics, Inc. (OBLN): Price and Financial Metrics
GET POWR RATINGS... FREE!
OBLN POWR Grades
- Growth is the dimension where OBLN ranks best; there it ranks ahead of 72.72% of US stocks.
- The strongest trend for OBLN is in Value, which has been heading down over the past 31 weeks.
- OBLN's current lowest rank is in the Quality metric (where it is better than 1.42% of US stocks).
OBLN Stock Summary
- With a market capitalization of $30,565,782, Obalon Therapeutics Inc has a greater market value than only 5% of US stocks.
- As for revenue growth, note that OBLN's revenue has grown -64.65% over the past 12 months; that beats the revenue growth of only 4.22% of US companies in our set.
- In terms of volatility of its share price, OBLN is more volatile than 96.8% of stocks we're observing.
- Stocks with similar financial metrics, market capitalization, and price volatility to Obalon Therapeutics Inc are NBRV, SNOA, CEI, FTK, and NBY.
- OBLN's SEC filings can be seen here. And to visit Obalon Therapeutics Inc's official web site, go to www.obalon.com.
OBLN Stock Price Chart Interactive Chart >
OBLN Price/Volume Stats
|Current price||$3.05||52-week high||$10.77|
|Prev. close||$3.24||52-week low||$0.66|
|Day high||$4.80||Avg. volume||7,677,330|
|50-day MA||$2.88||Dividend yield||N/A|
|200-day MA||$2.30||Market Cap||30.57M|
Obalon Therapeutics, Inc. (OBLN) Company Bio
Obalon Therapeutics, a commercial-stage medical device company, focuses on developing and commercializing medical devices to treat obese and overweight people by facilitating weight loss. It offers the Obalon balloon system designed to provide weight loss in obese patients. The company was founded in 2008 and is based in Carlsbad, California.
OBLN Latest News Stream
|Loading, please wait...|
OBLN Latest Social Stream
View Full OBLN Social Stream
Latest OBLN News From Around the Web
Below are the latest news stories about Obalon Therapeutics Inc that investors may wish to consider to help them evaluate OBLN as an investment opportunity.
No summary available.
No summary available.
DGAP-News: ReShape Lifesciences Inc. and Obalon Therapeutics, Inc. Update on Status of Pending Merger
DGAP-News: ReShape Lifesciences Inc. / Key word(s): Merger ReShape Lifesciences Inc. and Obalon Therapeutics, Inc. Update on Status of Pending Merger 08.06.2021 / 13:30 The issuer is solely responsible for the content of this announcement. ReShape Lifesciences Inc. and Obalon Therapeutics, Inc. Update on Status of Pending
SAN CLEMENTE, CA and SAN DIEGO, CA / ACCESSWIRE / June 8, 2021 / ReShape Lifesciences Inc. (OTCQB:RSLS) and Obalon Therapeutics, Inc.
Reminder: Obalon Therapeutics, Inc. Urges Stockholders to IMMEDIATELY Vote FOR All Proposals Related to the Merger with ReShape Lifesciences Inc
OBLN Price Returns
Continue Researching OBLNWant to do more research on Obalon Therapeutics Inc's stock and its price? Try the links below:
Obalon Therapeutics Inc (OBLN) Stock Price | Nasdaq
Obalon Therapeutics Inc (OBLN) Stock Quote, History and News - Yahoo Finance
Obalon Therapeutics Inc (OBLN) Stock Price and Basic Information | MarketWatch